ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

COGT Cogent Biosciences Inc

6.60
0.10 (1.54%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Cogent Biosciences Inc COGT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.10 1.54% 6.60 09:00:00
개장가 저가 고가 종가 전일 종가
6.50 6.46 7.257 6.93 6.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202422:00GLOBECogent Biosciences Presents Data Highlighting Potential..
27/02/202406:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/02/202423:13EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/02/202422:30EDGAR2Form 8-K - Current report
26/02/202422:00GLOBECogent Biosciences Reports Recent Business Highlights and..
23/02/202404:30GLOBECogent Biosciences Announces Positive Part 1b Data from..
17/02/202408:55EDGAR2Form SC 13D/A - General statement of acquisition of..
17/02/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202402:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:35EDGAR2Form 8-K - Current report
14/02/202421:00GLOBECogent Biosciences Announces Oversubscribed $225 Million..
10/02/202406:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/02/202423:00GLOBECogent Biosciences to Present SUMMIT Part 1b Data with..
26/01/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202422:00GLOBECogent Biosciences Announces Planned 2024 Milestones for..
05/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202422:00GLOBECogent Biosciences Announces Presentation at the 42nd Annual..
11/12/202322:04EDGAR2Form 8-K - Current report
11/12/202321:55GLOBECogent Biosciences Announces Positive Data from Ongoing..
10/12/202303:30GLOBECogent Biosciences Announces Positive Initial Data from..
07/12/202323:00GLOBECogent Biosciences Presents New Preclinical Data..
04/12/202322:00GLOBECogent Biosciences to Host Investor Webcast on December 11,..
29/11/202322:00GLOBECogent Biosciences Announces Poster Presentations at..
07/11/202321:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:18EDGAR2Form 8-K - Current report
02/11/202322:00GLOBECogent Biosciences Reports Recent Business Highlights and..
15/10/202301:30GLOBECogent Biosciences Presents Preclinical Data Highlighting..
04/10/202305:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/08/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:14EDGAR2Form 8-K - Current report
08/08/202321:00GLOBECogent Biosciences Reports Recent Business Highlights and..
06/07/202305:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202305:01GLOBECogent Biosciences Announces Closing of Upsized Public..
07/06/202322:00GLOBECogent Biosciences Announces Participation in the Jefferies..
07/06/202309:25GLOBECogent Biosciences Announces Pricing of Upsized Public..
07/06/202305:05GLOBECogent Biosciences Announces Proposed Public Offering of..
04/06/202303:15GLOBECogent Biosciences Announces Positive Lead-In Data from..
23/05/202321:00GLOBECogent Biosciences to Host Investor Webcast to Discuss..
09/05/202321:00GLOBECogent Biosciences Reports Recent Business Highlights and..

최근 히스토리

Delayed Upgrade Clock